Some patients experience weight regain (WR) or insufficient weight loss (IWL) after bariatric
surgery (BS). We undertook a scoping review of WR and IWL after BS. We searched …

Abstract Purpose of Review Although bariatric surgery is the most effective treatment of
severe obesity, a proportion of patients experience clinically significant weight regain (WR) …

Importance Metabolic surgery leads to weight loss and improved health, but these outcomes
are highly variable. Poor weight loss is associated with lower circulating levels of glucagon …

Purpose Weight regain after bariatric surgery occurs in up to a third of patients and reduces
treatment-associated health benefits. The efficacy of glucagon-like peptide-1 receptor …

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are indicated in type 2 diabetes and
obesity for their high efficacy in controlling glycaemia and inducing body weight loss …

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established in clinical
practice for the treatment of type 2 diabetes, and are approved and recommended for weight …

Objective The aim of this study was to compare the effectiveness of semaglutide versus
liraglutide for treating post‐metabolic and bariatric surgery (MBS) weight recurrence …

Purpose Bariatric surgery is a successful obesity treatment; however, an estimated 1/5 of
patients have regained more than 15% of their body weight 5 years post-surgery. To …

The 21st century is characterized by an increasing incidence and prevalence of obesity and
the burden of its associated comorbidities, especially cardiometabolic diseases, which are …

Context Weight regain (WR) after bariatric surgery is emerging as a common clinical
problem due to the increase in the number of procedures performed. Early interventions are …